Evidence map›Paper›PMID 19350248›Full record

ArticleEuropean radiology2009

Penumbra Stroke System as an "add-on" for the treatment of large vessel occlusive disease following thrombolysis: first results.

Tobias Struffert, Martin Köhrmann, Tobias Engelhorn, Tim Nowe, Gregor Richter, Peter D Schellinger, Stefan Schwab, Arnd Doerfler

Abstract read
PubMed Publisher
In one paragraph

Article in European radiology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 40 citations in OpenAlex.

  1. Guideline
  2. Trial
  3. Article
  4. Endovascular therapy for ischemic stroke.Journal of clinical neurology (Seoul, Korea) · 2015
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. The usefulness of compliant balloon for recanalization of acute ischemic stroke.Journal of cerebrovascular and endovascular neurosurgery · 2012
    Article
  10. Article
  11. Article
  12. Article
  13. Advances in stroke therapy.Drug delivery and translational research · 2011
    Article
  14. Article
  15. Achieving faster recanalization times by IA thrombolysis in acute ischemic stroke: where should we direct our efforts?Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences · 2011
    Article
  16. Article
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Tobias StruffertDepartment of Neuroradiology, University of Erlangen-Nuremberg, Schwabachanlage 6, Erlangen 91054, Germany. tobias.struffert@uk-erlangen.de
Martin Köhrmann
Tobias Engelhorn
Tim Nowe
Gregor Richter
Peter D Schellinger
Stefan Schwab
Arnd Doerfler
Friedrich-Alexander-Universität Erlangen-Nürnberg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Penumbra Stroke System (PSS) was cleared for use in patients with ischemic stroke by the FDA in January 2008. We describe our experience of using this new system in acute large vessel occlusive disease following thrombolysis. Fifteen consecutive patients (mean age 60 years) suffering from acute ischemic stroke were treated with the PSS after intravenous or intra-arterial standard treatment with tissue plasminogen activator (n = 14) or ReoPro (n = 1). All patients presented with TIMI 3 before use of the PSS. Carotid stenting (n = 3) and intracranial balloon angioplasty or stenting (n = 2) were performed if indicated. Neurological evaluation was performed using the NIHSS score and the mRS score. Initial median NIHSS score in 12 patients with occlusions in the anterior circulation was 15; three patients with basilar artery occlusion presented with coma. Median symptom to procedure start time was 151 min. In the anterior circulation, 9 of the 12 target vessels were recanalised successfully (TIMI 2 and 3). The rate of patients with independent clinical outcome (mRS </= 2) was 42%. One patient died 5 days after unsuccessful treatment, one after 28 days and one after 85 days owing to heart attack. Basilar artery occlusions could be recanalised in all cases to TIMI 3. The clinical result after 90 days was mRS 4 in two cases and mRS 5 in one case. Symptomatic haemorrhage did not occur. The PSS can safely be used for recanalisation in patients with acute ischemic stroke due to large vessel occlusion, who have already received thrombolysis treatment. The recanalisation rate was 80%. Symptomatic haemorrhage did not occur. Randomized trials may demonstrate that endovascular mechanical thrombectomy improves patient outcome.

Indexed as

AdultAgedAged, 80 and overArterial Occlusive DiseasesCerebral Arterial DiseasesCombined Modality TherapyEmbolization, TherapeuticEquipment DesignEquipment Failure AnalysisFemaleHumansMaleMiddle AgedPilot ProjectsRetrospective StudiesThrombolytic Therapy

Identifiers

PMID19350248
OpenAlexW2037420562

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.